Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16.
Lancet Neurol. 2021.
PMID: 33212063
Clinical Trial.
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy.
Obici L, Ajroud-Driss S, Lin KP, Berk JL, Gillmore JD, Kale P, Koike H, Danese D, Aldinc E, Chen C, Vest J, Adams D; HELIOS-A Collaborators Study Group.
Obici L, et al.
Neurol Ther. 2023 Oct;12(5):1759-1775. doi: 10.1007/s40120-023-00522-4. Epub 2023 Jul 31.
Neurol Ther. 2023.
PMID: 37523143
Free PMC article.
Item in Clipboard
Genetic Study of Early Onset Parkinson's Disease in Cyprus.
Abu Manneh R, Chairta PP, Mitsi E, Loizidou MA, Georgiou AN, Christou YP, Pantzaris M, Zamba-Papanicolaou E, Hadjisavvas A.
Abu Manneh R, et al.
Int J Mol Sci. 2022 Dec 6;23(23):15369. doi: 10.3390/ijms232315369.
Int J Mol Sci. 2022.
PMID: 36499697
Free PMC article.
Item in Clipboard
Cite
Cite